Unlocking the Potential of iPSC Therapies for Parkinson’s Disease
Time: 9:30 am
day: Conference Day Two
Details:
- Investigating the expanding application of iPSC technology to create cell-based therapies for Parkinson’s disease
- Highlighting the importance of developing reliable preclinical models to assess the safety and effectiveness of iPSC therapies in Parkinson’s disease
